With one published mutation in IFT43 in CED [27] and our findings in two SRPS cases, it is unclear whether the clinical consequences of IFT43 mutations, either CED or SRPS, depend on the specific nature of the identified mutations or on other genetic or stochastic factors. Here, IFT43 is linked to cranioectodermal dysplasia.